Search

everythinglearnresearchcommunity

for

Search:↓

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

PCOS is a major cause of infertility and requires personalized treatment.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early treatment of PCOS is crucial for better health and quality of life.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.